Lv1
43 积分 2021-01-25 加入
Metastatic site and clinical outcome of patients with deficient mismatch repair metastatic colorectal cancer treated with an immune checkpoint inhibitor in the first-line setting
9天前
已完结
Nivolumab plus ipilimumab versus nivolumab in microsatellite instability-high metastatic colorectal cancer (CheckMate 8HW): a randomised, open-label, phase 3 trial
10天前
已完结
Nivolumab plus Ipilimumab in Microsatellite-Instability–High Metastatic Colorectal Cancer
10天前
已完结
Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers
11天前
已完结
Data from First-Line Apatinib Combined with Tislelizumab and Chemotherapy for Patients with Advanced Gastric and Gastroesophageal Junction Adenocarcinoma with Poor Prognosis
16天前
已完结
Patterns in genomic mutations among patients with early-onset colorectal cancer: an international, multicohort, observational study
18天前
已完结
Modeling Population-Level Impacts of Cell-Free DNA Screening for Colorectal Cancer in Canada
18天前
已完结
Diabetes and Colorectal Cancer Risk and Survival According to Tumor Immunity Status
18天前
已关闭
A Novel Adjuvant Chemoradiotherapy/Immunotherapy for Resected Biliary Cancer
25天前
已完结
Adjuvant Chemoradiation and Immunotherapy for Extrahepatic Cholangiocarcinoma and Gallbladder Cancer
25天前
已完结
皖公网安备34019202002308
